Client stories · Project accounts
What directors remember after the briefing room
These accounts come from pharmaceutical commercial and medical affairs teams who commissioned field analytics engagements. Names are withheld where clients requested confidentiality.
Short testimonials
The call frequency audit showed our Suwon district reps were clustering visits at three large hospitals while community clinics in the same postal band went untouched. We had suspected it but never had the heat map to show the regional VP.
— Field Force Manager, cardiovascular franchise, national pharma
Sample distribution analysis flagged a clinic receiving triple the sample volume relative to visit count. Compliance used the appendix directly in their internal review — saved us a separate investigation.
— Commercial Operations Lead, specialty pharma
The prescription trend briefing slides were dense — perhaps too dense for a first read. We asked for a simplified executive summary and received it within three days at no extra charge.
— Franchise Head, oncology, mid-size pharma
Quarterly territory review arrived on week twelve as promised. One annotation on the Goyang cluster turned out to be based on a physician ID we had retired — Hazel Base corrected it within 48 hours of our note.
— Regional Medical Affairs Director, immunology
Extended project account: Gyeonggi oncology franchise
Engagement: Quarterly Territory Review
Scope: 38 districts, one oncology molecule, Q1–Q3 call and sample data
Challenge: The client had reorganised territories mid-year. CRM records still mapped reps to old boundaries, making internal reports unreliable for cycle planning.
Our work: We reconstructed boundary assignments from roster change logs, re-allocated historical calls to current districts, and overlaid prescription panel data licensed by the client. The briefing identified four districts where call activity increased but prescription share declined — a pattern the internal dashboard had masked.
Outcome: The regional director used the briefing to justify redistributing two rep assignments before the October cycle. The client re-engaged for Q4 within two weeks of delivery.
Extended project account: Sample compliance preparation
A specialty pharma compliance officer commissioned a sample distribution analysis six weeks before an internal audit. Shipment records spanned two product lines with inconsistent lot numbering. Our data coordinator normalised lot fields in week one and flagged 11 outlier accounts by week five. The compliance team incorporated our summary into their audit binder without modification. The officer noted the engagement cost less than contracting a general consultancy that would have required additional onboarding on pharmaceutical sample regulations.
Discuss your field data